Pulmonology

The HCPLive Infectious Disease condition center page is a comprehensive resource for clinical news and insights on respiratory health. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for asthma, COPD, interstitial lung disease, COVID-19, and more.

Latest News

Pulmonology Month in Review: March 2024
Pulmonology Month in Review: March 2024

April 3rd 2024

In this Month in Review article for March, news on topics such as asthma and the impacts of pollution in the pulmonology field were highlighted.

Older Adults More Likely to Have Inappropriately Diagnosed Community-Acquired Pneumonia
Older Adults More Likely to Have Inappropriately Diagnosed Community-Acquired Pneumonia

April 3rd 2024

Deepak Bhatt, MD, MPH, MBA | Credit: Mount Sinai Heart
Recapping Q1 2024 FDA Decisions in Cardiology, with Deepak Bhatt, MD, MPH, MBA

April 2nd 2024

COPD, IPF Linked to More Severe COVID-19 Outcomes, Mortality Risk
COPD, IPF Linked to More Severe COVID-19 Outcomes, Mortality Risk

April 1st 2024

Short-Term Biofeedback Therapies Lead to Alleviation of Certain Long COVID Symptoms
Short-Term Biofeedback Therapies Lead to Alleviation of Certain Long COVID Symptoms

March 28th 2024

Latest CME Events & Activities

Addressing Healthcare Inequities: Tailoring Management Plans to Address Healthcare Disparities in Cystic Fibrosis

View More

Revolutionizing Early-Stage NSCLC Treatment: Pathologists’ Key Insights into Predicting Pathologic Responses to Immunotherapies

View More

Community Practice Connections™: 20th Annual Winter Lung Conference

View More

Medical Crossfire®: Key Strategies to Prioritize Testing and the Evolving Role of Genomic Alterations in Providing Precision NSCLC Care

View More

Breaking Down Biomarkers in Non–Small Cell Lung Cancer: A Case-Based Discussion for the Oncology Nurse

View More

Go To PER in Chicago

May 31, 2024 - June 2, 2024

Register Now!

The Top 10 Oncogenic Drivers in NSCLC for 2023: What You Need to Know on Tumor Testing, Targets, and Treatment Strategies to Move the Field Forward

View More

Respiratory Syncytial Virus: Understanding the Infection Burden and Anticipating the Impact of Vaccines

View More

Engaging the Multidisciplinary Care Team to Optimize Care of Patients With EGFR Mutation–Positive NSCLC: A Lung Cancer Tumor Board

View More

Expanding the Armamentarium of Actionable Mutations in NSCLC: Uncovering the Potential of CEACAM5 as a Therapeutic Target

View More

25th Annual International Lung Cancer Congress®

July 25-27, 2024

Register Now!

24th Annual International Lung Cancer Congress®

View More

Engaging the Multidisciplinary Care Team to Optimize Care of Patients With EGFR Mutation-Positive NSCLC: A Lung Cancer Tumor Board

View More

Pathology Implications for CEACAM5 as a Therapeutic Target in Advanced NSCLC

View More

Medical Crossfire®: What Are Effective Strategies for Onco-Nurses to Improve Outcomes in Patients with Small Cell Lung Cancer?

View More

Advances In™: Aligning Pathology and Oncology Efforts in the Community to Improve NSCLC Care

View More

Community Practice Connections: 7th Annual School of Nursing Oncology™

View More

6th Annual Precision Medicine Symposium: An Illustrated Tumor Board

October 18-19, 2024

Register Now!

Virtual Show Me the Data™: How HER2, HER3, and TROP2 Targeted Strategies Will Impact Evolving Paradigms in NSCLC

View More

6th Annual Advanced Practice Collaborative

View More

Community Practice Connections™: 24th Annual International Lung Cancer Congress®

View More

42nd Annual CFS®: Innovative Cancer Therapy for Tomorrow®

November 13-15, 2024

Register Now!

19th Annual New York Lung Cancers Symposium®

November 16, 2024

Register Now!

Let’s Get “Real”: Alpha-1 Antitrypsin Deficiency—Case-Based Perspectives on Managing Associated Emphysema

View More

Shaping the Management of COPD with Biologic Therapy

View More

Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes

View More

EGPA: Highlighting the Patient Journey to Improve the Differential Diagnosis and Accelerate the Initiation of Guideline-Based Care

View More

Identifying Actionable Biomarkers in NSCLC: Real World Case Discussions on Applications of Testing in the Treatment Planning Process

View More

How CEACAM5 Expression Can Be Measured and Leveraged in NSCLC Care: Current Developments & Future Therapeutic Opportunities

View More

Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC

View More

More News

© 2024 MJH Life Sciences

All rights reserved.